Calpain Inhibitor III structure
|
Common Name | Calpain Inhibitor III | ||
---|---|---|---|---|
CAS Number | 88191-84-8 | Molecular Weight | 382.45 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 450.4±45.0 °C at 760 mmHg | |
Molecular Formula | C22H26N2O4 | Melting Point | N/A | |
MSDS | USA | Flash Point | 226.2±28.7 °C |
Use of Calpain Inhibitor IIIcysteine protease inhibitor of calpain that rapidly penetrates the blood-brain barrier following systemic administration[1][2]. MDL-28170 also block γ-secretase[4]. |
Name | Z-Val-Phe-H |
---|---|
Synonym | More Synonyms |
Description | cysteine protease inhibitor of calpain that rapidly penetrates the blood-brain barrier following systemic administration[1][2]. MDL-28170 also block γ-secretase[4]. |
---|---|
Related Catalog | |
Target |
Calpain[1]. |
In Vitro | MDL-28170 significantly and time-dependently improves the recovery of synaptic responses in hippocampal slices following prolonged, moderate hypoxia without hypoxic depolarization[1]. MDL-28170 dose-dependently inhibits brain cysteine proteinase activity (in vitro Ki= 0.01 μM)[2]. |
In Vivo | Treatment with MDL-28170 (50 mg/kg, i.p.) completely prevents the striatal damage in four animals in each of the two treatment groups. The numbers of necrotic neurons are reduced by 85% and 68% in animals in which MDL-28170 injections are initiated at 0.5 and 3 h of recirculation, respectively[2]. MDL-28170 (30 mg/kg, i.p.) reduces the functional and structural deterioration of corpus callosum following fluid percussion injury[3]. MDL-28170 (10 mg/kg, i.p.) significantly improves nerve function parameters in diabetic rats. MDL-28170 (3 and 10 mg/kg, i.p.) improves nociceptive behavior in diabetic rats[5]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 450.4±45.0 °C at 760 mmHg |
Molecular Formula | C22H26N2O4 |
Molecular Weight | 382.45 |
Flash Point | 226.2±28.7 °C |
PSA | 84.50000 |
LogP | 3.77 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.571 |
Storage condition | 2-8℃ |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | 22-24/25 |
RIDADR | NONH for all modes of transport |
Impaired Focal Adhesion Kinase-Grb2 Interaction during Elevated Activity in Hippocampal Neurons.
Int. J. Mol. Sci. 16 , 15659-69, (2015) Excitatory/inhibitory imbalances are implicated in many neurological disorders. Previously, we showed that chronically elevated network activity induces vulnerability in neurons due to loss of signal ... |
|
A recoverable state of axon injury persists for hours after spinal cord contusion in vivo.
Nat. Commun. 5 , 5683, (2014) Therapeutic strategies for spinal cord injury (SCI) commonly focus on regenerating disconnected axons. An alternative approach would be to maintain continuity of damaged axons, especially after contus... |
|
Different patterns of electrical activity lead to long-term potentiation by activating different intracellular pathways.
J. Neurosci. 35(2) , 621-33, (2015) Deciphering and storing information coded in different firing patterns are important properties of neuronal networks, as they allow organisms to respond and adapt to external and internal events. Here... |
CARBOBEZOXY-VALINYL-PHENYLALANINALZ-VAL-PHE-CHO |
MFCD00798796 |
Carbamic acid, N-[(1S)-1-[[[(1S)-1-formyl-2-phenylethyl]amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester |
Carbamic acid, N-[(1S)-1-formyl-2-phenylethyl]-, phenylmethyl ester |
N-benzyloxycarbonyl-(S)-valinylphenylalaninal |
benzyl [(2S)-1-oxo-3-phenylpropan-2-yl]carbamate |
Benzyl [(2S)-3-methyl-1-oxo-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]amino}butan-2-yl]carbamate |
Z-Val-Phe-H |
Z-VAL-PHE-CHO |
(S)-(-)-2-(Benzylcarbonylamino)-3-phenylpropanal |
Z-L-Val-L-Phe-OH |
Benzyl [(2S)-1-oxo-3-phenyl-2-propanyl]carbamate |
CARBOBENZOXY-VALINYL-PHENYLALANINAL |
CALPAIN INHIBITOR III |
Benzyl [(2S)-3-methyl-1-oxo-1-{[(2S)-1-oxo-3-phenyl-2-propanyl]amino}-2-butanyl]carbamate |
Cbz-L-Val-L-Phe-OH |
Z-VAL-PHE-ALDEHYDE |
MDL 28170 |
MDL-28170 |